These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6105786)

  • 1. Anticholinergics promote neuroleptic-induced tardive dyskinesia.
    Borison RL; Diamond BI
    Adv Biochem Psychopharmacol; 1980; 24():359-61. PubMed ID: 6105786
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Domino EF
    Psychopharmacology Suppl; 1985; 2():217-23. PubMed ID: 2860660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone prevents and blocks the emergence of neuroleptic-mediated oral stereotypic behaviors.
    Pollock J; Kornetsky C
    Neuropsychopharmacology; 1991 Jun; 4(4):245-9. PubMed ID: 1678260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin: perchance an endogenous neuroleptic?
    Nemeroff CB
    Biol Psychiatry; 1980 Apr; 15(2):283-302. PubMed ID: 6106513
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
    Marshall AM; Mishra RK
    Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ketamine-induced rat model of tardive dyskinesia.
    Marco LA; Joshi RS
    Prog Neurobiol; 1992 Jun; 38(6):571-600. PubMed ID: 1350352
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic-induced marching-in-place.
    Frost L; Lal S; Yassa R
    Acta Psychiatr Scand; 1989 Jan; 79(1):48-51. PubMed ID: 2564722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical methods for predicting the occurrence of tardive dyskinesia.
    Bürki HR
    Commun Psychopharmacol; 1979; 3(1):7-15. PubMed ID: 38033
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
    Maj J; Sowińska H; Baran L; Sarnek J
    Eur J Pharmacol; 1974 Apr; 26(1):9-14. PubMed ID: 4857604
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of dopamine receptor sensitivity by estrogen.
    Gordon JH; Borison RL; Diamond BI
    Biol Psychiatry; 1980 Jun; 15(3):389-96. PubMed ID: 7189674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occurrence of tardive dyskinesia during neuroleptic treatment].
    Fanget F; Henry E; Aimard G
    Presse Med; 1986 Dec; 15(43):2147-50. PubMed ID: 2884657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotyped hand clasping: an unusual tardive movement disorder.
    Kaneko K; Yuasa T; Miyatake T; Tsuji S
    Mov Disord; 1993 Apr; 8(2):230-1. PubMed ID: 8474498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Allen RM
    Biol Psychiatry; 1982 Jun; 17(6):719-27. PubMed ID: 6179548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.